IDIBAPS and FCRB among the Spanish institutions with more funds under the H2020 Health Social Challenge

In early October, the Centre for the Industrial and Technological Development (CDTI) released the 2014 provisional results about the Spanish participation in Horizon 2020 (H2020) under the Social Challenge 1: "Health, Demographic Change and wellness". During 2014, IDIBAPS and FCRB were granted a total of 7 projects and a total funding of 3.061.398 euros.

The report publishes a ranking of the 16 most important Spanish institutions in terms of economic return. In this ranking, IDIBAPS stands out in fourth position with 3 projects funded and FCRB in the ninth position with 4 of them. The good results at the institutional level are also reflected in our researchers’ participation in approved projects in the 2014-2015 H2020 program:

Call

Project

Principal Investigator

Institution

Societal challenge 1: Personalising Health and Care

2014

Cost effective self-management of urinary incontinence addressed to women (WOMEN-UP)

Dra. Montse Espuña

FCRB

2015

Development of a systems biomedicine approach for risk identification, prevention and treatment of type 2 diabetes (T2DSystems)

Dr. Jorge Ferrer

IDIBAPS

2015

A EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates (EHVA)

Dr. Jose Maria Gatell

IDIBAPS

2014

Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease (CARBALIVE)

Dr. Pere Ginès

IDIBAPS

2015

European AIDS Vaccine Initiative 2020 (EAVI2020)

Dr. Joan Joseph

FCRB

2014

Evaluating mHealth technology in HIV to improve Empowerment and healthcare utilisation (EmERGE)

Dra. Agata León

FCRB

2015

Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities (HEP-CAR)

Dr. Josep Maria Llovet

IDIBAPS

2014

Characterizing Atrial fibrillation by Translating its Causes into Health Modifiers in the Elderly (CATCH ME)

Dr. Lluís Mont

IDIBAPS

2014

Sustainable intEgrated care modeLs for multi-morbidity: delivery, FInancing and performance (SELFIE)

Dr. Josep Roca

IDIBAPS

2014

Aortic Valve Replacement using Individualised Regenerative Allografts: Bridging the Therapeutic Gap (ARISE)

Dra. Marta Sitges

IDIBAPS

2014

Conservative iron chelation as a disease-modifying strategy in Parkinsons disease: a multicentric parallel-group,placebo-controlled, randomized clinical trial of deferiprone (FAIR-PARK-II)

Dr. Eduardo Tolosa

FCRB

Excellent Science: Marie Sklodowska- Curie actions

Innovative Training Networks 2014

Computational and functional annotation of genomic elements during development of the model vertebrate zebrafish (ZENCODE)

Dr. Jorge Ferrer

IDIBAPS

Individual Fellowships 2014

Analysis of tridimensional changes caused by type 2 Diabetes-Associated varianTs (3D-ADAPT)

Dra. Irene Miguel-Escalada

IDIBAPS

Innovative Training Networks 2015

Regulation of red cell life-span, erythropoiesis, survival, senescence and clearance (RELEVANCE)

Dr. Joan Lluís VivesCorrons

IDIBAPS

Industrial Leadership: Leadership in Enabling and Industrial Technologies

ICT- 2015

Laser and Ultrasound Co-Analyzer for thyroid nodules (LUCA)

Dr. Ramon Gomis

IDIBAPS

ICT- 2014

A Framework for user centred privacy and security in the cloud (CLARUS)

Dr. David Vidal

FCRB

3rd Health Programme (CHAFEA)

2014

Stimulating Innovation Management of Polypharmacy and Adherence in The Elderly (SIMPATHY)

Dr. Carles Codina

FCRB

ERA-NETS

EraCoSysMed2015

Personalizing health care in Multiple Sclerosis using systems medicine tolos (Sys4MS)

Dr. Pablo Villoslada (Coordinator)

IDIBAPS

eRARE2015

A comprehensive clinical and experimental approach to personalized molecular medicine in patients with defined and undefined autoinflammatory disorders (INSAID)

Dr. Juan Aróstegui

FCRB

TransCan2015

Genetic and cellular intratumor heterogeneity as predictor of chronic lymphocytic leukemiaoutco resistance (GCH-CLL)

Dr. Elias Campo

FCRB

InfectEra2015

SRCR proteins as microorganism pattern recognition receptors: a wide search for interactions with pathogenic bacteria (SRecognite)

Dr. Francisco Lozano

IDIBAPS

NEURON 2014

Advancing an antigen-specific nanomedicine for the treatment of central nervous system autoimmunity (MS NANOMED)

Dr. Pau Serra

FCRB

FET Flagships

Human Brain Project

Slow Wave Dynamics: from experiments, analysis and models to rhythm restoration (SloW-Dyn)

Dra. Maria Victoria Sánchez (Coordinator)

IDIBAPS

Human Brain Project

WAVE SCALing Experiments and Simulations (WaveScalIES)

Dra. Maria Victoria Sánchez

IDIBAPS

Graphene

Graphene-based disruptive technologies (Graphenecore 1)

Dra. Maria Victoria Sánchez

IDIBAPS

The report points out that Spain is the fourth country in terms of economic return with 9% after the United Kingdom (17.4%), the Netherlands (14.1%) and Germany (13, 6%) and with a success rate of 10.7% in Europe (EU-28). Spain obtained a total of 51.1 million euros.

Spanish institutions and companies are involved in 61 of the 114 activities that have received funding in the field of health; they lead 17 activities, of which 15 are Research and Innovation Action y Innovation Action proposals.

Notably, public research centers are in second place in terms of uptake of these resources and Catalonia is the region that leads the Spanish ranking.

The analysis is based on the first open calls within the new framework program. For more information, consult the CDTI report:

Spanish Participation in Horizon 2020: European Comission's framework program  (2014-2020)